Consistent with the hypothesis that MARCH2 enhances ALK5 activity and promotes TGF-β signaling, TCGA data analysis revealed a strong positive correlation between MARCH2 expression and the expression of TGF-β target genes in colon (Fig. 7F) and stomach cancers (Fig. S6). The gene discussed is MARCHF2; the disease is gastric neoplasm.